Abstract
Cemiplimab (LIBTAYO (R); cemiplimab-rwlc), a human programmed death receptor-1 (PD-1) monoclonal antibody that binds to PD-1 and blocks its interactio......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
